M. Romero

Hath1, Down-Regulated in Colon Adenocarcinomas, Inhibits Proliferation and Tumorigenesis of Colon Cancer Cells

C. Leow, M. Romero, S. Ross, 2004, Cancer Research.

Transcription factors CTCF and Pax6 are segregated to different cell types during retinal cell differentiation

M. Romero, R. Adler, M. V. Canto-Soler, 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

Combination efficacy with MetMAb and erlotinib in a NSCLC tumor model highlight therapeutic opportunities for c-Met inhibitors in combination with EGFR inhibitors

J. Zha, G. Woude, M. Romero, 2008 .

Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma

N. van Bruggen, H. Koeppen, S. Spencer, 2009, The Journal of pathology.

Proliferation and Tumorigenesis of Colon Cancer Cells Hath 1 , Down-Regulated in Colon Adenocarcinomas , Inhibits

C. Leow, M. Romero, S. Ross, 2004 .

Hath 1 , Down-Regulated in Colon Adenocarcinomas , Inhibits Proliferation and Tumorigenesis of Colon Cancer Cells

C. Leow, M. Romero, S. Ross, 2004 .

Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib.

Stuart Thomson, M. Sliwkowski, M. Romero, 2006, Cancer research.

One-armed 5D5 (OA5D5) is a potent humanized HGF-blocking anti-c-Met monovalent antibody that inhibits HGF-dependent activity in vitro and demonstrates anti-tumor efficacy in vivo

R. Carano, Minhong Yan, M. Merchant, 2007 .